| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 13.6 | 13.5 | 11.5 |
| Other income | 0.5 | 0.2 | 0.5 |
| Total income | 14.1 | 13.8 | 12.0 |
| Profit before exceptional items & tax | -0.5 | -0.4 | 0.8 |
| Profit before tax | -0.5 | -0.4 | 0.8 |
| Net profit | -0.3 | -0.3 | 0.3 |
| Operating margin | -3.5% | -2.9% | 6.7% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | +18.30% |
|---|
NSE results filing, NSE: LOTUSEYE. Figures extracted from the filing.
Lotus Eye Hospital and Institute Ltd: key numbers
- Share price
- ₹115.07
- Market cap
- ₹239.3 Cr
- Revenue (annual)
- ₹53.71 Cr
- Net profit (annual)
- ₹0.08 Cr
- P/E (TTM)
- 1602.9×Sector 57.8×
- Promoter holding
- 40.14%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Lotus Eye Hospital and Institute Ltd
All →Lotus Eye Hospital and Institute Annual General Meeting
Lotus Eye Hospital And Institute Limited held its 29th Annual General Meeting on September 23, 2026, via video conferencing to discuss company operations and financial highlights.
Lotus Eye Hospital and Institute Q1 FY27 Results: Net Profit ₹0.6 Cr, Up 20.0% YoY
Lotus Eye Hospital and Institute Ltd reported revenue from operations of ₹17.1 Cr (+26.7% YoY) and net profit of ₹0.6 Cr (+20.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.6 Cr · +20.0% YoY